Table 5.

Association between the CTI and CVD mortality according to Diabetes

	Died/participants	Model 1	Model 2	Model 3
Diabetes
CVD mortality	132/1632
Q1	15/135	1 (referent)	1 (referent)	1 (referent)
Q2	29/277	1.01 (0.54–1.87)	0.99 (0.53–1.85)	1.06 (0.57–1.96)
Q3	38/420	0.93 (0.51–1.69)	1.04 (0.57–1.90)	1.15 (0.63–2.12)
Q4	50/800	0.78 (0.44–1.39)	1.08 (0.60–1.92)	1.19 (0.60–2.23)
All-cause mortality	407/1632
Q1	34/135	1 (referent)	1 (referent)	1 (referent)
Q2	86/277	1.31 (0.88–1.95)	1.29 (0.87–1.93)	1.29 (0.86–1.97)
Q3	122/420	1.31 (0.89–1.91)	1.45 (0.99–2.12)	1.57 (1.04–2.24)*
Q4	165/800	1.12 (0.77–1.62)	1.48 (1.02–2.14)*	1.61 (1.07–2.34)*
Total-CVD	418/1632
Q1	37/135	1 (referent)	1 (referent)	1 (referent)
Q2	79/277	1.06 (0.67–1.67)	0.96 (0.59–1.55)	0.86 (0.49–1.45)
Q3	101/420	0.84 (0.54–1.30)	0.79 (0.50–1.26)	0.63 (0.38–1.05)
Q4	201/800	0.89 (0.59–1.34)	1.03 (0.67–1.59)	0.76 (0.41–1.17)
Non-diabetes
CVD mortality	228/7047
Q1	48/2035	1 (referent)	1 (referent)	1 (referent)
Q2	62/1893	0.94 (0.64–1.40)	0.97 (0.67–1.42)	1.52 (1.06–2.21)*
Q3	70/1750	1.21 (0.80–1.81)	1.21 (0.84–1.75)	1.89 (1.33–2.91)**
Q4	48/1369	1.72 (1.08–2.74)*	1.76 (1.17–2.63)**	2.21 (1.49–3.28)**
All-cause mortality	745/7047
Q1	171/2035	1 (referent)	1 (referent)	1 (referent)
Q2	227/1893	1.04 (0.84–1.27)	1.01 (0.83–1.23)	1.55 (1.23–1.81)**
Q3	213/1750	1.11 (0.89–1.39)	1.05 (0.86–1.28)	1.63 (1.39–2.03)**
Q4	134/1369	1.48 (1.14–1.92)**	1.36 (1.08–1.70)**	1.75 (1.41–2.18)**
Total-CVD	554/7047
Q1	103/2035	1 (referent)	1 (referent)	1 (referent)
Q2	151/1893	1.08 (0.81–1.45)	1.14 (0.87–1.50)	1.65 (1.31–2.11)**
Q3	146/1750	1.03 (0.76–1.41)	1.12 (0.85–1.48)	1.72 (1.36–2.25)**
Q4	154/1369	1.45 (1.04–2.02)**	1.84 (1.40–2.42)**	2.44 (1.83–3.06)**

Model 1 did not adjust for any variables. Model 2 adjusted for sex and age. Model 3 adjusted for age, sex, education, race, smoking, alcohol use, self-reported diabetes, self-reported hypertension, systolic blood pressure (SBP), BMI, HDL, LDL, and HbA1c% levels

*P < 0.05, **P < 0.01